BioCentury
ARTICLE | Strategy

Leverage for Chiron's vaccines

September 5, 1995 7:00 AM UTC

Leverage for Chiron's vaccines

Concurrently with the merger agreement between Univax Biologics Inc. and North American Biologicals Inc., UNVX announced it was adding to its pipeline via a collaborative agreement with Chiron Corp. to develop immunotherapeutics based on vaccines in development at Chiron Biocine. ...